Skip to search.
 TSX Down 0.09% TSX Ventures Down 0.48%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.71 Down 0.03(1.72%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:1.74
Open:1.75
Bid:1.70 x 40000
Ask:1.77 x 1000
1y Target Est:5.30
Beta:1.64
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:1.69 - 1.76
52wk Range:1.69 - 3.23
Volume:1,882,938
Avg Vol (3m):3,414,140
Market Cap:308.22M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CTICDown 1.72%308.22M
BMYDown 0.86%113.85B
RHHBYDown 0.94%N/A
SNYDown 1.01%132.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.36
Quarterly EPS Est (Jun-15) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback